1,432
Views
37
CrossRef citations to date
0
Altmetric
Original Articles

Standardization of Nomenclature for Ocular Tuberculosis – Results of Collaborative Ocular Tuberculosis Study (COTS) Workshop

, MD, FRCSORCID Icon, , MDORCID Icon, , PhD, , MMed, , MD, , MBBS, , PhD, , MS, , MD, , FRCOphthORCID Icon, , MD, , MDORCID Icon, , MD, , MD, , DNB, , MD, , MD, , MD, , MDORCID Icon, , MD, , FRCOphth, , PhD, , MD, , PhD, , MD, , MDORCID Icon, , MDORCID Icon, , MD, , MD, , DNB, , MD, , MD, , MD, , MD, , MD, , MD, , MD, , PhD, , MD, , MDORCID Icon, ORCID Icon, , PhD, , PhD, , PhD, , PhD, , PhDORCID Icon, , PhD, , MD, , DNB, , MS, , MDORCID Icon, , DNB, , DNB, , PhD, , MS, , PhD, , MD, , MD, , PhD, , FRCOphth, , MD, , MD, , MD, , MD, , PhD, , DNB, , PhD, , MD, , MD, , MD, , PhD, , PhD, , FRCS, , PhDORCID Icon, , MSORCID Icon, , MS, , MS, , MD, , FRCS, , MD, , FRCS, , DNB, , PhD, , PhD, , MD, , MD, , MD, , PhD, , PhD, , FRCOphth, , MS & show all
Pages 74-84 | Received 03 Aug 2019, Accepted 06 Aug 2019, Published online: 10 Dec 2019

REFERENCES

  • Agrawal R, Gunasekeran DV, Raje D, et al. Global variations and challenges with tubercular uveitis in the Collaborative Ocular Tuberculosis Study. Invest Ophthalmol Vis Sci. 2018;59(10):4162–4171. doi:10.1167/iovs.18-24102.
  • Agrawal R, Gunasekeran DV, Grant R, et al. Clinical features and outcomes of patients with tubercular uveitis treated with antitubercular therapy in the Collaborative Ocular Tuberculosis Study (COTS)-1. JAMA Ophthalmol. 2017;135(12):1318–1327. doi:10.1001/jamaophthalmol.2017.4485.
  • Ang M, Chee S-P. Controversies in ocular tuberculosis. Br J Ophthalmol. 2017;101(1):6–9. doi:10.1136/bjophthalmol-2016-309531.
  • Figueira L, Fonseca S, Ladeira I, et al. Ocular tuberculosis: Position paper on diagnosis and treatment management. Rev Port Pneumol (2006). 2017;23(1):31–38. doi:10.1016/j.rppnen.2016.10.004.
  • Lee C, Agrawal R, Pavesio C. Ocular tuberculosis–a clinical conundrum. Ocul Immunol Inflamm. 2016;24(2):237–242. doi:10.3109/09273948.2014.985387.
  • Gupta V, Shoughy SS, Mahajan S, et al. Clinics of ocular tuberculosis. Ocul Immunol Inflamm. 2015;23(1):14–24. doi:10.3109/09273948.2014.986582.
  • Gupta V, Gupta A, Rao NA. Intraocular tuberculosis–an update. Surv Ophthalmol. 2007;52(6):561–587. doi:10.1016/j.survophthal.2007.08.015.
  • Lou SM, Larkin KL, Winthrop K, et al. Lack of consensus in the diagnosis and treatment for ocular tuberculosis among uveitis specialists. Ocul Immunol Inflamm. 2015;23(1):25–31. doi:10.3109/09273948.2014.926936.
  • Ang M, Vasconcelos-Santos DV, Sharma K, et al. Diagnosis of Ocular Tuberculosis. Ocul Immunol Inflamm. 2018;26(2):208–216. doi:10.1080/09273948.2016.1178304.
  • Verma A, Biswas J, Dhanurekha L, et al. Detection of Mycobacterium tuberculosis with nested polymerase chain reaction analysis in enucleated eye ball in Eales’ disease. Int Ophthalmol. 2016;36(3):413–417. doi:10.1007/s10792-015-0144-9.
  • Rajpal, Singh UB, Mohapatra S, et al. Association of Mycobacterium tuberculosis in the causation of Eales’ disease: an institutional experience. Indian J Med Microbiol. 2015;33 Suppl:43–45. doi:10.4103/0255-0857.148829.
  • Biswas J, Ravi RK, Naryanasamy A, et al. Eales’ disease - current concepts in diagnosis and management. J Ophthalmic Inflamm Infect. 2013;3(1):11. doi:10.1186/1869-5760-3-11.
  • Gunasekeran DV, Agrawal R, Agarwal A, et al. THE COLLABORATIVE OCULAR TUBERCULOSIS STUDY (COTS)-1: A multinational review of 251 patients with tubercular retinal vasculitis. Retina (Philadelphia, Pa). April 2018. doi:10.1097/IAE.0000000000002194.
  • Agrawal R, Gunasekeran DV, Gonzalez-Lopez JJ, et al. PERIPHERAL RETINAL VASCULITIS: Analysis of 110 Consecutive Cases and a Contemporary Reappraisal of Tubercular Etiology. Retina (Philadelphia, PA). 2017;37(1):112–117. doi:10.1097/IAE.0000000000001239.
  • Rosenbaum JT, Sibley CH, Lin P. Retinal vasculitis. Curr Opin Rheumatol. 2016;28(3):228–235. doi:10.1097/BOR.0000000000000271.
  • Agarwal A, Karkhur S, Aggarwal K, et al. Epidemiology and clinical features of inflammatory retinal vascular occlusions: pooled data from two tertiary-referral institutions. Clin Exp Ophthalmol. 2018;46(1):62–74. doi:10.1111/ceo.12997.
  • Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005;140(3):509–516. doi:10.1016/j.ajo.2005.03.057.
  • Nazari Khanamiri H, Rao NA. Serpiginous choroiditis and infectious multifocal serpiginoid choroiditis. Surv Ophthalmol. 2013;58(3):203–232. doi:10.1016/j.survophthal.2012.08.008.
  • Kawali A, Emerson GG, Naik NK, et al. Clinicopathologic features of tuberculous serpiginous-like choroiditis. JAMA Ophthalmol. 2018;136(2):219–221. doi:10.1001/jamaophthalmol.2017.5791.
  • Bansal R, Gupta A, Gupta V, et al. Tubercular serpiginous-like choroiditis presenting as multifocal serpiginoid choroiditis. Ophthalmology. 2012;119(11):2334–2342. doi:10.1016/j.ophtha.2012.05.034.
  • Agrawal R, Gupta B, González-López JJ, et al. Spectrum of choroidal involvement in presumed ocular tuberculosis: report from a population with low endemic setting for tuberculosis. Ocul Immunol Inflamm. 2017;25(1):97–104. doi:10.3109/09273948.2015.1087577.
  • Invernizzi A, Agarwal A, Mapelli C, et al. Longitudinal follow-up of choroidal granulomas using enhanced depth imaging optical coherence tomography. Retina (Philadelphia, Pa). 2017;37(1):144–153. doi:10.1097/IAE.0000000000001128.
  • Invernizzi A, Mapelli C, Viola F, et al. Choroidal granulomas visualized by enhanced depth imaging optical coherence tomography. Retina (Philadelphia, Pa). 2015;35(3):525–531. doi:10.1097/IAE.0000000000000312.
  • Biswas J, Shome D. Choroidal tubercles in disseminated tuberculosis diagnosed by the polymerase chain reaction of aqueous humor. A case report and review of the literature. Ocul Immunol Inflamm. 2002;10:293–298.
  • Mehta S. Healing patterns of choroidal tubercles after antitubercular therapy : A photographic and OCT study. J Ophthalmic Inflamm Infect. 2012;2(2):95–97. doi:10.1007/s12348-011-0040-z.
  • Mehta S. Fundus fluorescein angiography of choroidal tubercles: case reports and review of literature. Indian J Ophthalmol. 2006;54(4):273–275. doi:10.4103/0301-4738.27956.
  • Ganesh SK, Ali BS. Paradoxical worsening of a case of TB subretinal abscess with serpiginous-like choroiditis following the initiation of antitubercular therapy. Indian J Ophthalmol. 2017;65(8):761–764. doi:10.4103/ijo.IJO_184_17.
  • Bukhary ZA, Alrajhi AA. Tuberculosis treatment outcome in a tertiary care setting. Ann Saudi Med. 2007;27(3):171–174. doi:10.5144/0256-4947.2007.171.
  • Campbell IA, Bah-Sow O. Pulmonary tuberculosis: diagnosis and treatment. BMJ. 2006;332(7551):1194–1197. doi:10.1136/bmj.332.7551.1194.
  • World Health Organization. Treatment of Tuberculosis: 2017 Update. http://www.tbonline.info/media/uploads/documents/who_guidelines.pdf. Accessed May 7, 2019.
  • Agarwal A, Aggarwal K, Deokar A, et al. Optical coherence tomography angiography features of paradoxical worsening in tubercular multifocal serpiginoid choroiditis. Ocul Immunol Inflamm. 2016;24(6):621–630. doi:10.1080/09273948.2016.1207785.
  • Esen E, Sızmaz S, Kunt Z, Demircan N. Paradoxical worsening of tubercular serpiginous-like choroiditis after initiation of antitubercular therapy. Turk J Ophthalmol. 2016;46(4):186–189. doi:10.4274/tjo.94809.
  • Cheung CMG, Chee SP. Jarisch-Herxheimer reaction: paradoxical worsening of tuberculosis chorioretinitis following initiation of antituberculous therapy. Eye (Lond). 2009;23(6):1472–1473. doi:10.1038/eye.2008.204.
  • Gupta V, Bansal R, Gupta A. Continuous progression of tubercular serpiginous-like choroiditis after initiating antituberculosis treatment. Am J Ophthalmol. 2011;152(5):857–863.e2. doi:10.1016/j.ajo.2011.05.004.
  • Aggarwal K, Agarwal A, Deokar A, et al. Ultra-wide field imaging in paradoxical worsening of tubercular multifocal serpiginoid choroiditis after the initiation of anti-tubercular therapy. Ocul Immunol Inflamm. October 2017;1–6. doi:10.1080/09273948.2017.1373829.
  • Biswas J, Pal B, Gondhale HP, et al. Long-term outcomes of a large cohort of patients with Eales’ disease. Ocul Immunol Inflamm. April 2017:1–7. doi:10.1080/09273948.2017.1298817.
  • Okada AA, Jabs DA. The standardization of uveitis nomenclature project: the future is here. JAMA Ophthalmol. 2013;131(6):787–789. doi:10.1001/jamaophthalmol.2013.1596.
  • Oliver GF, Stathis RM, Spurrier NJ, et al. Use of standardization of uveitis nomenclature for reporting clinical data at 10 years. Ophthalmology. 2017;124(7):1084–1085. doi:10.1016/j.ophtha.2017.03.009.
  • Jabs DA, Dick A, Doucette JT, et al. Interobserver agreement among uveitis experts on uveitic diagnoses: the standardization of uveitis nomenclature experience. Am J Ophthalmol. 2018;186:19–24. doi:10.1016/j.ajo.2017.10.028.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.